Skip to content

‘$1 trillion gap’ attracts private equity to women’s health, says Kearney’s Paula Bellostas Muguerza; Astorg, Cinven, Nordic target pathology assets

0.3861
Chimera Difficulty Score
a synthesis of Flesch-Kincaid, Coleman-Liau, SMOG, and Dale-Chall readability metrics
Healthcare‘$1 trillion gap’ attracts private equity to women’s health, says Kearney’s Paula Bellostas Muguerza; Astorg, Cinven, Nordic target pathology assetsJohn R Fischer - 3 hours ago Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
The narrative of private equity rushing into women’s health frames the sector as both a moral imperative and a financial opportunity. At its strongest, this argument highlights a genuine market failure—decades of underinvestment in women’s health have left gaps that private capital could fill, potentially driving innovation and accessibility. The focus on pathology assets suggests a strategic bet on diagnostics, a high-margin area with scalable potential. Yet, the pattern of private equity’s inv...